Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Review ArticleMinireview

Aryl Hydrocarbon Receptor as a Therapeutical Target of Environmentally Induced Skin Conditions

Caroline de Almeida Freitas Accioli, Michelle Sabrina da Silva, Bianca Aloise Maneira Corrêa Santos and Carlos Rangel Rodrigues
Molecular Pharmacology May 2023, 103 (5) 255-265; DOI: https://doi.org/10.1124/molpharm.122.000627
Caroline de Almeida Freitas Accioli
Laboratório de Planejamento Farmacêutico e Simulação Computacional (LaPFarSC) (C.d.A.F.A., B.A.M.C.S.) and Laboratório de Modelagem Molecular & QSAR-3D (ModMolQSAR), Departamento de Fármacos e Medicamentos (DEFARMED) (C.R.R.), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil and MEDCINVITRO, São Paulo, Brazil (M.S.d.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Caroline de Almeida Freitas Accioli
Michelle Sabrina da Silva
Laboratório de Planejamento Farmacêutico e Simulação Computacional (LaPFarSC) (C.d.A.F.A., B.A.M.C.S.) and Laboratório de Modelagem Molecular & QSAR-3D (ModMolQSAR), Departamento de Fármacos e Medicamentos (DEFARMED) (C.R.R.), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil and MEDCINVITRO, São Paulo, Brazil (M.S.d.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michelle Sabrina da Silva
Bianca Aloise Maneira Corrêa Santos
Laboratório de Planejamento Farmacêutico e Simulação Computacional (LaPFarSC) (C.d.A.F.A., B.A.M.C.S.) and Laboratório de Modelagem Molecular & QSAR-3D (ModMolQSAR), Departamento de Fármacos e Medicamentos (DEFARMED) (C.R.R.), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil and MEDCINVITRO, São Paulo, Brazil (M.S.d.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bianca Aloise Maneira Corrêa Santos
Carlos Rangel Rodrigues
Laboratório de Planejamento Farmacêutico e Simulação Computacional (LaPFarSC) (C.d.A.F.A., B.A.M.C.S.) and Laboratório de Modelagem Molecular & QSAR-3D (ModMolQSAR), Departamento de Fármacos e Medicamentos (DEFARMED) (C.R.R.), Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil and MEDCINVITRO, São Paulo, Brazil (M.S.d.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos Rangel Rodrigues
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 103 (5)
Molecular Pharmacology
Vol. 103, Issue 5
1 May 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Aryl Hydrocarbon Receptor as a Therapeutical Target of Environmentally Induced Skin Conditions
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleMinireview

AhR Modulation in Environmentally Induced Skin Conditions

Caroline de Almeida Freitas Accioli, Michelle Sabrina da Silva, Bianca Aloise Maneira Corrêa Santos and Carlos Rangel Rodrigues
Molecular Pharmacology May 1, 2023, 103 (5) 255-265; DOI: https://doi.org/10.1124/molpharm.122.000627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Review ArticleMinireview

AhR Modulation in Environmentally Induced Skin Conditions

Caroline de Almeida Freitas Accioli, Michelle Sabrina da Silva, Bianca Aloise Maneira Corrêa Santos and Carlos Rangel Rodrigues
Molecular Pharmacology May 1, 2023, 103 (5) 255-265; DOI: https://doi.org/10.1124/molpharm.122.000627
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • The AhR and Its Mechanism of Ligand Activation
    • Role of AhR in Skin Physiologic and Pathologic Processes
    • External Factors That Activate the AhR Pathway
    • AhR Modulation as a Therapeutic Target for Skin Conditions
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Ferroptosis and Breast Cancer
  • LncRNAs Associated With Neuroinflammation
Show more Minireview

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics